New Survey Identifies Opportunity to Improve Shared Decision Making Between Cardiologists and Heart Valve Disease Patients New findings from an American College of Cardiology’s survey revealed more than half of cardiologists believe patient preparation may lead to better quality discussions around treatment options for heart valve disease . Results from the ACC CardioSurve panelist survey, sponsored by Medtronic and conducted by the American College of Cardiology, garnered responses from more than 150 cardiologists around key factors … – New findings from an American College of Cardiology’s (ACC) survey revealed more than half of cardiologists (57%) believe patient preparation may lead to better quality discussions around treatment options for heart valve disease (HVD). Results from the ACC CardioSurve panelist survey, sponsored by Medtronic (NYSE: MDT), and conducted by the American College of Cardiology, garnered responses from more than 150 cardiologists around key factors driving treatment choices for patients with symptomatic severe aortic stenosis. The data was published in the April 2021 Cardiology Magazine and will be presented Sunday during the virtual symposium at ACC’s 70 th Annual Scientific Session, A Practical Approach to Shared Decision-Making when Treating HVD .